Andrew Dreyfus is President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts. Serving nearly 3 million members, BCBSMA is one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country. As CEO, Andrew leads the company’s effort to make quality health care affordable.
Prior to being named CEO in September 2010, Andrew served as BCBSMA’s Executive Vice President of Health Care Services. In that position, he led the company’s collaborative efforts to improve the quality and safety of health care in Massachusetts, including the development of BCBSMA’s Alternative Quality Contract, one of the largest commercial payment reform initiatives in the nation.
Andrew previously served as the first President of the Blue Cross Blue Shield of Massachusetts Foundation, which works to expand access to health care for Massachusetts residents. During his tenure, the Foundation launched a series of policy initiatives, including the “Roadmap to Coverage,” which contributed to the successful passage of the state’s landmark 2006 Health Reform Law.
Before joining Blue Cross Blue Shield of Massachusetts, Andrew was Executive Vice President of the Massachusetts Hospital Association (MHA), and held a number of senior positions in Massachusetts state government, including Undersecretary of Consumer Affairs and Business Regulation and Director of Communications and Operations in the Executive Office of Health and Human Services.
Andrew serves on the boards of the National Institute for Health Care Management (NIHCM), Ironwood Pharmaceuticals, Jobs for Massachusetts, and the advisory board of Ariadne Labs. Andrew is a founding member of the Massachusetts Coalition for Serious Illness Care as well as a member on the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Quality Care for People with Serious Illness. He has given presentations on health care reform at the Wharton School of the University of Pennsylvania and Harvard School of Business, the Commonwealth Fund and at the United States Senate.